Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-Oct-21 9:51 PM View:  | Sab Biotherapeutics, Inc. (SABS) | 22-Oct-21 | Grant | 4,974,500 | -- | -- | 100% 0 to 4.97M | |
| 26-Oct-21 9:51 PM View: | Sab Biotherapeutics, Inc. (SABS) | 22-Oct-21 | Grant Duplicate | 5,049,350 | -- | -- | 102% 4.97M to 10.02M | |
| 26-Oct-21 9:51 PM View: | Sab Biotherapeutics, Inc. (SABS) | 14-Oct-21 | Grant | 5,092 | $10.10 | $51,429.20 | 20% 25.0K to 30.09K | (22%) |
| 26-Oct-21 9:51 PM View: | Sab Biotherapeutics, Inc. (SABS) | 13-Oct-21 | Grant | 20,800 | $10.10 | $210,080.00 | 83% 25.0K to 45.8K | (22%) |
| 26-Oct-21 9:51 PM View: | Sab Biotherapeutics, Inc. (SABS) | 12-Oct-21 | Grant | 50,000 | $10.09 | $504,250.00 | (200%) (-25.0K) to 25.0K | (22%) |
| 26-Oct-21 9:51 PM View: | Sab Biotherapeutics, Inc. (SABS) | 01-Oct-21 | Grant | 2,695 | $10.10 | $27,219.50 | 100% 0 to 2.69K | (22%) |